129 related articles for article (PubMed ID: 31362265)
1. UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts.
Williams AP; Garner EF; Stafman LL; Aye JM; Quinn CH; Marayati R; Stewart JE; Atigadda VR; Mroczek-Musulman E; Moore BP; Beierle EA; Friedman GK
Transl Oncol; 2019 Oct; 12(10):1364-1374. PubMed ID: 31362265
[TBL] [Abstract][Full Text] [Related]
2. 9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts.
Marayati R; Bownes LV; Stafman LL; Williams AP; Quinn CH; Atigadda V; Aye JM; Stewart JE; Yoon KJ; Beierle EA
Transl Oncol; 2021 Jan; 14(1):100893. PubMed ID: 33010553
[TBL] [Abstract][Full Text] [Related]
3. UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts.
Garner EF; Stafman LL; Williams AP; Aye JM; Goolsby C; Atigadda VR; Moore BP; Nan L; Stewart JE; Hjelmeland AB; Friedman GK; Beierle EA
J Neurooncol; 2018 Nov; 140(2):209-224. PubMed ID: 30132166
[TBL] [Abstract][Full Text] [Related]
4. Novel second-generation rexinoid induces growth arrest and reduces cancer cell stemness in human neuroblastoma patient-derived xenografts.
Marayati R; Bownes LV; Quinn CH; Wadhwani N; Williams AP; Markert HR; Atigadda V; Aye JM; Stewart JE; Yoon KJ; Beierle EA
J Pediatr Surg; 2021 Jun; 56(6):1165-1173. PubMed ID: 33762121
[TBL] [Abstract][Full Text] [Related]
5. Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastoma.
Marayati R; Williams AP; Bownes LV; Quinn CH; Stewart JE; Mroczek-Musulman E; Atigadda VR; Beierle EA
J Pediatr Surg; 2020 Jun; 55(6):1072-1080. PubMed ID: 32164984
[TBL] [Abstract][Full Text] [Related]
6. Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma.
Stafman LL; Williams AP; Garner EF; Aye JM; Stewart JE; Yoon KJ; Whelan K; Beierle EA
Transl Oncol; 2019 Feb; 12(2):200-208. PubMed ID: 30412911
[TBL] [Abstract][Full Text] [Related]
7. Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses.
Friedman GK; Moore BP; Nan L; Kelly VM; Etminan T; Langford CP; Xu H; Han X; Markert JM; Beierle EA; Gillespie GY
Neuro Oncol; 2016 Feb; 18(2):227-35. PubMed ID: 26188016
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype.
Srivastava VK; Nalbantoglu J
Cytometry A; 2008 Oct; 73(10):940-8. PubMed ID: 18773455
[TBL] [Abstract][Full Text] [Related]
9. A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro.
Williams AP; Waters AM; Stewart JE; Atigadda VR; Mroczek-Musulman E; Muccio DD; Grubbs CJ; Beierle EA
J Surg Res; 2018 Aug; 228():54-62. PubMed ID: 29907230
[TBL] [Abstract][Full Text] [Related]
10. Minnelide effectively eliminates CD133(+) side population in pancreatic cancer.
Nomura A; McGinn O; Dudeja V; Sangwan V; Saluja AK; Banerjee S
Mol Cancer; 2015 Nov; 14():200. PubMed ID: 26597727
[TBL] [Abstract][Full Text] [Related]
11. A possible interplay between HR-HPV and stemness in tumor development: an in vivo investigation of CD133 as a putative marker of cancer stem cell in HPV18-infected KB cell line.
de Maria S; Santoro A; Fuggetta MP; Rocchetti R; Cottarelli A; Lanzilli G; Stiuso P; Angelico G; Spadola S; Franco Zannoni G; Rubini C; Emanuelli M; Carmela Pedicillo M; Pannone G; Muzio LL
APMIS; 2020 Dec; 128(12):637-646. PubMed ID: 32911563
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a subpopulation of CD133
Gao J; Yang T; Wang X; Zhang Y; Wang J; Zhang B; Tang D; Liu Y; Gao T; Lin Q; Tang J; Cai J
Cancer Cell Int; 2021 Mar; 21(1):157. PubMed ID: 33685462
[TBL] [Abstract][Full Text] [Related]
13. Tumor environment dictates medulloblastoma cancer stem cell expression and invasive phenotype.
Annabi B; Rojas-Sutterlin S; Laflamme C; Lachambre MP; Rolland Y; Sartelet H; Béliveau R
Mol Cancer Res; 2008 Jun; 6(6):907-16. PubMed ID: 18567795
[TBL] [Abstract][Full Text] [Related]
14. Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia.
Blazek ER; Foutch JL; Maki G
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):1-5. PubMed ID: 17084552
[TBL] [Abstract][Full Text] [Related]
15. Acquisition of tumorigenic potential and therapeutic resistance in CD133+ subpopulation of prostate cancer cells exhibiting stem-cell like characteristics.
Kanwal R; Shukla S; Walker E; Gupta S
Cancer Lett; 2018 Aug; 430():25-33. PubMed ID: 29775627
[TBL] [Abstract][Full Text] [Related]
16. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Evaluation of UAB30 in Pediatric Renal and Hepatic Malignancies.
Waters AM; Stewart JE; Atigadda VR; Mroczek-Musulman E; Muccio DD; Grubbs CJ; Beierle EA
Mol Cancer Ther; 2016 May; 15(5):911-21. PubMed ID: 26873726
[TBL] [Abstract][Full Text] [Related]
18. HDAC and MAPK/ERK Inhibitors Cooperate To Reduce Viability and Stemness in Medulloblastoma.
da Cunha Jaeger M; Ghisleni EC; Cardoso PS; Siniglaglia M; Falcon T; Brunetto AT; Brunetto AL; de Farias CB; Taylor MD; Nör C; Ramaswamy V; Roesler R
J Mol Neurosci; 2020 Jun; 70(6):981-992. PubMed ID: 32056089
[TBL] [Abstract][Full Text] [Related]
19. [Isolation and characterization of brain tumor stem cells in human medulloblastoma].
Li MC; Deng YW; Wu J; Chen FH; Liu JF; Fang JS
Ai Zheng; 2006 Feb; 25(2):241-6. PubMed ID: 16480595
[TBL] [Abstract][Full Text] [Related]
20. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.
Chiou SH; Yu CC; Huang CY; Lin SC; Liu CJ; Tsai TH; Chou SH; Chien CS; Ku HH; Lo JF
Clin Cancer Res; 2008 Jul; 14(13):4085-95. PubMed ID: 18593985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
